Protara Therapeutics Inc
NASDAQ:TARA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protara Therapeutics Inc
NASDAQ:TARA
|
US |
|
E
|
Evolva Holding SA
XBER:ADF
|
CH |
|
D
|
Duke Energy Corp
XHAM:D2MN
|
US |
|
T
|
Terumo Corp
F:TUO
|
JP |
|
B
|
Bank of Montreal
F:BZZ
|
CA |
|
Metro AG
XETRA:B4B3
|
DE |
|
Beneteau SA
F:3GD
|
FR |
|
Biffa PLC
LSE:BIFF
|
UK |
|
S
|
SGL Carbon SE
XBER:SGL
|
DE |
|
B
|
Bidvest Group Ltd
XMUN:NQL1
|
ZA |
|
Snam SpA
OTC:SNMRF
|
IT |
|
N
|
Nimbus Group AB (publ)
STO:BOAT
|
SE |
|
E
|
Elsoft Research Bhd
KLSE:ELSOFT
|
MY |
|
B
|
Boston Scientific Corp
XMUN:BSX
|
US |
|
AIX Inc
NASDAQ:AIFU
|
CN |
|
H
|
Hextar Global Bhd
KLSE:HEXCARE
|
MY |
|
Bowen Coking Coal Ltd
ASX:BCB
|
AU |
|
L
|
Lynas Rare Earths Ltd
XHAM:LYI
|
MY |
Wall St Price Targets
TARA Price Targets Summary
Protara Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TARA is 26.01 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TARA's stock price target?
Price Target
26.01
USD
According to Wall Street analysts, the average 1-year price target for
TARA is 26.01 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.